Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Mirco Bartolomei"'
Autor:
Luca Urso, Corrado Cittanti, Luigi Manco, Naima Ortolan, Francesca Borgia, Antonio Malorgio, Giovanni Scribano, Edoardo Mastella, Massimo Guidoboni, Antonio Stefanelli, Alessandro Turra, Mirco Bartolomei
Publikováno v:
Diagnostics, Vol 14, Iss 12, p 1264 (2024)
Oligometastatic patients at [18F]F-Fluorocholine (18F-choline) PET/CT may be treated with metastasis-directed therapy (MDT). The aim of this study was to combine radiomic parameters extracted from 18F-choline PET/CT and clinical data to build machine
Externí odkaz:
https://doaj.org/article/a163d270e319473f947f31e5b795fa97
Autor:
Alberto Nieri, Luca Urso, Matteo Caracciolo, Maria Ciccone, Licia Uccelli, Corrado Cittanti, Antonio Cuneo, Mirco Bartolomei
Publikováno v:
Asia Oceania Journal of Nuclear Medicine and Biology, Vol 11, Iss 2, Pp 171-174 (2023)
Hodgkin Lymphoma (HL) is a malignancy involving lymph nodes and lymphatic system. [18F]F-FDG PET/CT (FDG-PET) imaging is routinely used for staging, to assess early chemotherapy response (interim FDG-PET), at the end of treatment (EoT FDG-PET) and fo
Externí odkaz:
https://doaj.org/article/682a07be22cc4da38470e899e9d2d8f1
Autor:
Giovanni Di Domenico, Simona Di Biaso, Lorenzo Longo, Alessandro Turra, Eugenia Tonini, MariaConcetta Longo, Licia Uccelli, Mirco Bartolomei
Publikováno v:
EJNMMI Physics, Vol 10, Iss 1, Pp 1-18 (2023)
Abstract Purpose Monte Carlo (MC) simulation in Nuclear Medicine is a powerful tool for modeling many physical phenomena which are difficult to track or measure directly. MC simulation in SPECT/CT imaging is particularly suitable for optimizing the q
Externí odkaz:
https://doaj.org/article/f788c4ab26674b2ea458a8363883c637
Publikováno v:
IEEE Journal of Selected Topics in Applied Earth Observations and Remote Sensing, Vol 16, Pp 2318-2326 (2023)
The presence of artificial light at night is not only limiting astronomical observations but has been linked to negative effects on human health and behavior of wildlife. New measurement systems are therefore needed to monitor artificial light emissi
Externí odkaz:
https://doaj.org/article/5d811a0ee6984210a809ad92b232a268
Autor:
Luca Urso, Luca Filippi, Angelo Castello, Maria Cristina Marzola, Mirco Bartolomei, Corrado Cittanti, Luigia Florimonte, Massimo Castellani, Paolo Zucali, Alessio Bruni, Roberto Sabbatini, Massimo Dominici, Stefano Panareo, Laura Evangelista
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 22, p 7130 (2023)
Background: prostate-specific membrane antigen (PSMA) ligand PET has been recently incorporated into international guidelines for several different indications in prostate cancer (PCa) patients. However, there are still some open questions regarding
Externí odkaz:
https://doaj.org/article/6f270d25d81d4eaaa799d22e7675cf72
Autor:
Matteo Caracciolo, Angelo Castello, Luca Urso, Francesca Borgia, Maria Cristina Marzola, Licia Uccelli, Corrado Cittanti, Mirco Bartolomei, Massimo Castellani, Egesta Lopci
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 16, p 5355 (2023)
The purpose of this systematic review was to investigate the diagnostic accuracy of [18F]FDG PET/CT and breast MRI for primary breast cancer (BC) response assessment after neoadjuvant chemotherapy (NAC) and to evaluate future perspectives in this set
Externí odkaz:
https://doaj.org/article/25ea2680b835470a8b019f7891b48526
Autor:
Natale Quartuccio, Pierpaolo Alongi, Luca Urso, Naima Ortolan, Francesca Borgia, Mirco Bartolomei, Gaspare Arnone, Laura Evangelista
Publikováno v:
Cancers, Vol 15, Iss 10, p 2715 (2023)
We investigated whether baseline [18F] Fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-derived semiquantitative parameters could predict disease-free survival (DFS) in patients with grade III breast cancer (BC) of different molecular
Externí odkaz:
https://doaj.org/article/a4ffcb8aba3f4773b9d3b313a1a56105
Autor:
Luca Urso, Elena Bonatto, Alberto Nieri, Angelo Castello, Anna Margherita Maffione, Maria Cristina Marzola, Corrado Cittanti, Mirco Bartolomei, Stefano Panareo, Luigi Mansi, Egesta Lopci, Luigia Florimonte, Massimo Castellani
Publikováno v:
Cancers, Vol 15, Iss 7, p 2184 (2023)
Over the last several years, molecular imaging has gained a primary role in the evaluation of patients with brain metastases (BM). Therefore, the “Response Assessment in Neuro-Oncology” (RANO) group recommends amino acid radiotracers for the asse
Externí odkaz:
https://doaj.org/article/e7e289c8322c4997a29738fbccbfc541
Autor:
Luca Urso, Alberto Nieri, Licia Uccelli, Angelo Castello, Paolo Artioli, Corrado Cittanti, Maria Cristina Marzola, Luigia Florimonte, Massimo Castellani, Sergio Bissoli, Francesca Porto, Alessandra Boschi, Laura Evangelista, Mirco Bartolomei
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1110 (2023)
Lutathera® is the first EMA- and FDA-approved radiopharmaceutical for radioligand therapy (RLT). Currently, on the legacy of the NETTER1 trial, only adult patients with progressive unresectable somatostatin receptor (SSTR) positive gastroenteropancr
Externí odkaz:
https://doaj.org/article/378435a6c4914f93a56c7b538e6a105f
Autor:
Luca Urso, Angelo Castello, Giorgio Treglia, Stefano Panareo, Alberto Nieri, Ilaria Rambaldi, Matteo Caracciolo, Naima Ortolan, Licia Uccelli, Corrado Cittanti, Massimo Castellani, Mirco Bartolomei
Publikováno v:
Diagnostics, Vol 13, Iss 4, p 606 (2023)
Background: this study aims to explore the prognostic and predictive role of volumetric parameters on [68Ga]Ga-DOTATOC PET/CT in neuroendocrine tumors (NET) patients treated with peptide receptor radionuclide therapy (PRRT). Methods: We retrospective
Externí odkaz:
https://doaj.org/article/cb69224df43f496d9c0bfaeafb6b3b1c